IPP Bureau
CanSinoBIO's Convidecia approved as heterologous booster in China
By IPP Bureau - February 21, 2022
Heterologous booster vaccination refers to the use of vaccine boosters from different technology platforms from the prime vaccines, which could improve the overall immune response and enhance protection against other variants
Binnopharm acquires two anti-bacterial brands from Dr. Reddy’s
By IPP Bureau - February 21, 2022
Dr. Reddy’s, will focus its resources and capabilities on its key therapy spaces of gastroenterology, pain management, cold and flu, allergy, oncology, neurology, paediatrics and women’s health as the Russia and CIS region continues to be a strong performer for the company
Strides receives USFDA approval for Amantadine Hydrochloride capsules
By IPP Bureau - February 21, 2022
To be marketed by Strides Pharma Inc. in the US market
IIT Delhi develops strategy for development of drug molecules
By IPP Bureau - February 21, 2022
The researchers are of the view that the new drug designing strategy demonstrated by them could also be adopted to treat retroviral infections.
Enhertu Phase III results to redefine how metastatic breast cancer is classifed
By IPP Bureau - February 21, 2022
Enhertu is a HER2-directed antibody drug conjugate (ADC) being jointly developed by AstraZeneca and Daiichi Sankyo.
Snowman Logistics expands its facility in Coimbatore
By IPP Bureau - February 21, 2022
The facility will cater to the storage, handling and transportation of pharma, dairy products seafood among others
Sputnik Light gets a boost as China changes rules on boosters
By IPP Bureau - February 21, 2022
Sputnik Light can become a major booster for those vaccinated with inactivated Chinese Covid-19 vaccines globally after China has officially recommended mix & match approach with adenoviral vector-based vaccines as boosters
Gujarat unveils ambitious Biotech Policy 2022-27
By IPP Bureau - February 21, 2022
According to the state government, it will also provide support to special projects such as preclinical testing, genome sequencing in the private sector, private sector BSL-3 lab-vaccine development and manufacturing and testing and certification laboratories
Vestige launches Pre-Gluco Health capsules for the early prevention of diabetes
By IPP Bureau - February 21, 2022
According to the Indian Journal of Medical Research in 2018, the estimated prevalence of pre-diabetes in India is 14%, which means that one out of six Indians is pre-diabetic
Panacea Biotech partners with GOI to develop protective vaccine against betacoronavirus
By IPP Bureau - February 21, 2022
CEPI is accelerating its programme to develop broadly protective coronavirus vaccines—a core part of US $ 3.5 billion pandemic preparedness plan
VitaDAO and Molecule AG partner with Apollo Health Ventures to build the longevity biotech & Web3 ecosystem
By IPP Bureau - February 21, 2022
By connecting a leading LongBio VC to the DeSci (decentralized science) movement, this partnership is a major milestone for the greater decentralized ecosystem
Valneva receives funding for Covid-19 vaccine from Scotland
By IPP Bureau - February 21, 2022
The grants are expected to be received over the next three years, commencing March 2022
Corbevax receives EUA for 12-18 age group
By IPP Bureau - February 21, 2022
It is India’s 1st indigenously developed Receptor Binding Domain Protein sub-unit vaccine against Covid-19
SEBI approves IPO plans of PharmEasy and Wellness Forever Medicare
By IPP Bureau - February 21, 2022
The companies plan to use the proceeds to retire debt and expand operations
Syncona completes sale of Gyroscope to Novartis
By IPP Bureau - February 20, 2022
The transaction generates upfront cash proceeds of $442 million for Syncona's holding in Gyroscope
